Adjunctive Bright Light Therapy for Opioid Use Disorder

Description

Investigators propose to conduct a pilot single-blind, parallel arm, randomized placebo-controlled trial evaluating the feasibility, acceptability, and preliminary efficacy of bright light therapy on reward system functioning among patients undergoing medication-assisted treatment for opioid use disorder.

Conditions

Opioid Use Disorder, Sleep Disturbance

Talk to us

Study Overview

On this page

Study Details

Study overview

Investigators propose to conduct a pilot single-blind, parallel arm, randomized placebo-controlled trial evaluating the feasibility, acceptability, and preliminary efficacy of bright light therapy on reward system functioning among patients undergoing medication-assisted treatment for opioid use disorder.

Adjunctive Wearable Bright Light Therapy for Patients With Opioid Use Disorder: A Pilot Study

Adjunctive Bright Light Therapy for Opioid Use Disorder

Condition
Opioid Use Disorder
Intervention / Treatment

-

Contacts and Locations

Phoenix

Arizona State University, Phoenix, Arizona, United States, 85004

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * age between 18 and 65
  • * ability to speak, write, and read in English
  • * past 2 weeks of insomnia as evidenced by Insomnia Severity Index (ISI) total score of ≥10
  • * enrolled in outpatient medication-assisted treatment for OUD (i.e., either methadone or buprenorphine treatment)
  • * been in medication-assisted treatment for at least 3 months
  • * at least one month of stable methadone or buprenorphine dose
  • * have a smartphone
  • * lifetime history of bipolar disorder or mania
  • * current narcolepsy, sleep paralysis, or restless leg syndrome as assessed by medical history
  • * history of seizure disorders/epilepsy
  • * the STOP-Bang score for obstructive sleep apnea ≥ 5
  • * retinal pathology, history of eye surgery or taking photosensitizing medications (e.g., lithium, L-tryptophan)
  • * current regular use of melatonin
  • * have circumstances that would interfere with study participation (e.g., impending jail sentence)
  • * previous experience with bright light therapy
  • * working a night shift or traveling outside the Arizona time zone in the past month
  • * pregnant, trying to get pregnant, or breastfeeding
  • * currently wearing prescription glasses with blue-light protection

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Arizona State University,

Chung Jung Mun, Ph.D., PRINCIPAL_INVESTIGATOR, Arizona State University

Study Record Dates

2025-05-31